| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | LIM domain binding | 2.99e-06 | 9 | 67 | 3 | GO:0030274 | |
| GeneOntologyMolecularFunction | actin binding | DST SPATA31A1 SPATA31A3 SPATA31A7 MYRIP AFDN NEB ACE SPATA31A6 SPATA31A5 | 4.19e-06 | 479 | 67 | 10 | GO:0003779 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | MAGI2 DST SPATA31A1 SPATA31A3 SPATA31A7 MYRIP AFDN FSD1 SAXO1 NEB ACE SPATA31A6 SPATA31A5 | 6.25e-05 | 1099 | 67 | 13 | GO:0008092 |
| Domain | DUF4599 | 6.89e-08 | 12 | 66 | 4 | PF15371 | |
| Domain | DUF4599 | 6.89e-08 | 12 | 66 | 4 | IPR027970 | |
| Domain | LIM-bd/SEUSS | 1.23e-05 | 2 | 66 | 2 | IPR029005 | |
| Domain | fn3 | 2.69e-04 | 162 | 66 | 5 | PF00041 | |
| Domain | FN3 | 4.95e-04 | 185 | 66 | 5 | SM00060 | |
| Domain | FN3 | 6.89e-04 | 199 | 66 | 5 | PS50853 | |
| Domain | FN3_dom | 8.59e-04 | 209 | 66 | 5 | IPR003961 | |
| Domain | Ankyrin_rpt | 2.33e-03 | 262 | 66 | 5 | IPR002110 | |
| Domain | SH3_9 | 2.65e-03 | 78 | 66 | 3 | PF14604 | |
| Domain | zf-CCHC | 2.97e-03 | 23 | 66 | 2 | PF00098 | |
| Pubmed | 1.59e-13 | 6 | 69 | 5 | 20850414 | ||
| Pubmed | Targeted disruption of the spermatid-specific gene Spata31 causes male infertility. | 1.59e-13 | 6 | 69 | 5 | 25930072 | |
| Pubmed | 1.09e-09 | 24 | 69 | 5 | 32212159 | ||
| Pubmed | 1.34e-06 | 709 | 69 | 10 | 22988430 | ||
| Pubmed | 2.68e-06 | 14 | 69 | 3 | 10981960 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 14516657 | ||
| Pubmed | Spliced isoforms of LIM-domain-binding protein (CLIM/NLI/Ldb) lacking the LIM-interaction domain. | 3.88e-06 | 2 | 69 | 2 | 16815859 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 9799849 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 21173732 | ||
| Pubmed | Comparative study of immunohistochemical expression of ERG and MAGI2 in prostatic carcinoma. | 3.88e-06 | 2 | 69 | 2 | 33713943 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 10083735 | ||
| Pubmed | A link between sICAM-1, ACE and parietal blood flow in the aging brain. | 3.88e-06 | 2 | 69 | 2 | 18243419 | |
| Pubmed | 7.32e-06 | 234 | 69 | 6 | 36243803 | ||
| Pubmed | MAGI2 DGLUCY DST LDB1 ERG GLS MYRIP CUL9 AFDN AIP ZNF785 LDB2 | 7.73e-06 | 1285 | 69 | 12 | 35914814 | |
| Pubmed | Tie2 regulates endocardial sprouting and myocardial trabeculation. | 1.05e-05 | 68 | 69 | 4 | 31112136 | |
| Pubmed | Identification of a common mesenchymal stromal progenitor for the adult haematopoietic niche. | 1.16e-05 | 3 | 69 | 2 | 27721421 | |
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 27129775 | ||
| Pubmed | Interactions of the LIM-domain-binding factor Ldb1 with LIM homeodomain proteins. | 1.16e-05 | 3 | 69 | 2 | 8918878 | |
| Pubmed | Lifelong haematopoiesis is established by hundreds of precursors throughout mammalian ontogeny. | 1.16e-05 | 3 | 69 | 2 | 28920953 | |
| Pubmed | ERG is required for the differentiation of embryonic stem cells along the endothelial lineage. | 1.16e-05 | 3 | 69 | 2 | 20030844 | |
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 25896473 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 19675209 | ||
| Pubmed | The stage-dependent roles of Ldb1 and functional redundancy with Ldb2 in mammalian retinogenesis. | 1.88e-05 | 26 | 69 | 3 | 27697904 | |
| Pubmed | 2.32e-05 | 4 | 69 | 2 | 18500345 | ||
| Pubmed | 2.32e-05 | 4 | 69 | 2 | 8954775 | ||
| Pubmed | Nedd4-2-dependent ubiquitylation and regulation of the cardiac potassium channel hERG1. | 2.32e-05 | 4 | 69 | 2 | 21463633 | |
| Pubmed | 3.86e-05 | 5 | 69 | 2 | 38695236 | ||
| Pubmed | 3.86e-05 | 5 | 69 | 2 | 22411555 | ||
| Pubmed | 3.86e-05 | 5 | 69 | 2 | 9860983 | ||
| Pubmed | 3.86e-05 | 5 | 69 | 2 | 36002265 | ||
| Pubmed | 5.21e-05 | 102 | 69 | 4 | 9734811 | ||
| Pubmed | 5.79e-05 | 6 | 69 | 2 | 10477764 | ||
| Pubmed | 5.79e-05 | 6 | 69 | 2 | 25893857 | ||
| Pubmed | Endothelium in the pharyngeal arches 3, 4 and 6 is derived from the second heart field. | 5.79e-05 | 6 | 69 | 2 | 27955943 | |
| Pubmed | 5.79e-05 | 6 | 69 | 2 | 20215856 | ||
| Pubmed | 5.79e-05 | 6 | 69 | 2 | 12368298 | ||
| Pubmed | 5.79e-05 | 6 | 69 | 2 | 9192866 | ||
| Pubmed | Impaired angiopoietin/Tie2 signaling compromises Schlemm's canal integrity and induces glaucoma. | 5.79e-05 | 6 | 69 | 2 | 28920924 | |
| Pubmed | 8.09e-05 | 7 | 69 | 2 | 15588578 | ||
| Pubmed | 8.09e-05 | 7 | 69 | 2 | 15282311 | ||
| Pubmed | 9.63e-05 | 371 | 69 | 6 | 15747579 | ||
| Pubmed | TMEM100 is a key factor for specification of lymphatic endothelial progenitors. | 1.08e-04 | 8 | 69 | 2 | 32112176 | |
| Pubmed | VEGF mediates commissural axon chemoattraction through its receptor Flk1. | 1.08e-04 | 8 | 69 | 2 | 21658588 | |
| Pubmed | 1.08e-04 | 8 | 69 | 2 | 36347256 | ||
| Pubmed | The identification of different endothelial cell populations within the mouse proepicardium. | 1.08e-04 | 8 | 69 | 2 | 21932312 | |
| Pubmed | 1.08e-04 | 8 | 69 | 2 | 23007406 | ||
| Pubmed | Robo4 is a vascular-specific receptor that inhibits endothelial migration. | 1.08e-04 | 8 | 69 | 2 | 12941633 | |
| Pubmed | 1.33e-04 | 130 | 69 | 4 | 12421765 | ||
| Pubmed | Proteolytic activation defines distinct lymphangiogenic mechanisms for VEGFC and VEGFD. | 1.38e-04 | 9 | 69 | 2 | 27159393 | |
| Pubmed | Dynamin genes Dnm1 and Dnm2 are located on proximal mouse chromosomes 2 and 9, respectively. | 1.38e-04 | 9 | 69 | 2 | 9143510 | |
| Pubmed | 1.38e-04 | 9 | 69 | 2 | 20018779 | ||
| Pubmed | Endothelial Progenitors Exist within the Kidney and Lung Mesenchyme. | 1.38e-04 | 9 | 69 | 2 | 23823180 | |
| Pubmed | 1.38e-04 | 9 | 69 | 2 | 28779009 | ||
| Pubmed | 1.71e-04 | 591 | 69 | 7 | 15231748 | ||
| Pubmed | 1.73e-04 | 10 | 69 | 2 | 18652815 | ||
| Pubmed | Role of cell and matrix-bound VEGF isoforms in lens development. | 2.11e-04 | 11 | 69 | 2 | 18757513 | |
| Pubmed | 2.11e-04 | 11 | 69 | 2 | 32140098 | ||
| Pubmed | Ubiquitination-dependent cofactor exchange on LIM homeodomain transcription factors. | 2.11e-04 | 11 | 69 | 2 | 11882901 | |
| Pubmed | Afadin Signaling at the Spinal Neuroepithelium Regulates Central Canal Formation and Gait Selection. | 2.53e-04 | 12 | 69 | 2 | 32521266 | |
| Pubmed | 2.53e-04 | 12 | 69 | 2 | 12619132 | ||
| Pubmed | 2.53e-04 | 12 | 69 | 2 | 17991461 | ||
| Pubmed | 2.53e-04 | 12 | 69 | 2 | 20208005 | ||
| Pubmed | 2.53e-04 | 12 | 69 | 2 | 10431247 | ||
| Pubmed | iSuRe-Cre is a genetic tool to reliably induce and report Cre-dependent genetic modifications. | 2.53e-04 | 12 | 69 | 2 | 31118412 | |
| Pubmed | Myc-dependent endothelial proliferation is controlled by phosphotyrosine 1212 in VEGF receptor-2. | 2.98e-04 | 13 | 69 | 2 | 31545012 | |
| Pubmed | HIF1α Represses Cell Stress Pathways to Allow Proliferation of Hypoxic Fetal Cardiomyocytes. | 2.98e-04 | 13 | 69 | 2 | 26028220 | |
| Pubmed | Endothelial marker-expressing stromal cells are critical for kidney formation. | 2.98e-04 | 13 | 69 | 2 | 28539333 | |
| Pubmed | 2.98e-04 | 13 | 69 | 2 | 25802403 | ||
| Pubmed | 2.98e-04 | 13 | 69 | 2 | 21354127 | ||
| Pubmed | BMP10 is essential for maintaining cardiac growth during murine cardiogenesis. | 2.98e-04 | 13 | 69 | 2 | 15073151 | |
| Pubmed | miR-126 regulates glycogen trophoblast proliferation and DNA methylation in the murine placenta. | 2.98e-04 | 13 | 69 | 2 | 30771304 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | 3.01e-04 | 861 | 69 | 8 | 36931259 | |
| Pubmed | 3.48e-04 | 14 | 69 | 2 | 33619517 | ||
| Pubmed | 3.48e-04 | 14 | 69 | 2 | 19380791 | ||
| Pubmed | Erythro-myeloid progenitors contribute endothelial cells to blood vessels. | 3.48e-04 | 14 | 69 | 2 | 30258231 | |
| Pubmed | Requirements for Jag1-Rbpj mediated Notch signaling during early mouse lens development. | 3.48e-04 | 14 | 69 | 2 | 22275127 | |
| Pubmed | 4.01e-04 | 15 | 69 | 2 | 23830865 | ||
| Pubmed | 4.01e-04 | 15 | 69 | 2 | 23236378 | ||
| Pubmed | 4.01e-04 | 15 | 69 | 2 | 26395479 | ||
| Pubmed | 4.01e-04 | 15 | 69 | 2 | 26985665 | ||
| Pubmed | Patterns of single-nucleotide polymorphisms in candidate genes for blood-pressure homeostasis. | 4.57e-04 | 16 | 69 | 2 | 10391210 | |
| Pubmed | LDB1 Is Required for the Early Development of the Dorsal Telencephalon and the Thalamus. | 4.57e-04 | 16 | 69 | 2 | 30873428 | |
| Pubmed | VEGF-C and aortic cardiomyocytes guide coronary artery stem development. | 4.57e-04 | 16 | 69 | 2 | 25271623 | |
| Pubmed | Fetal growth restriction in a genetic model of sporadic Beckwith-Wiedemann syndrome. | 4.57e-04 | 16 | 69 | 2 | 30158284 | |
| Pubmed | KLHL40 deficiency destabilizes thin filament proteins and promotes nemaline myopathy. | 4.57e-04 | 16 | 69 | 2 | 24960163 | |
| Pubmed | 4.57e-04 | 16 | 69 | 2 | 24727028 | ||
| Pubmed | 5.18e-04 | 17 | 69 | 2 | 9545490 | ||
| Pubmed | Endothelial deletion of Ino80 disrupts coronary angiogenesis and causes congenital heart disease. | 5.18e-04 | 17 | 69 | 2 | 29371594 | |
| Pubmed | Fetal overgrowth in the Cdkn1c mouse model of Beckwith-Wiedemann syndrome. | 5.81e-04 | 18 | 69 | 2 | 21729874 | |
| Pubmed | 6.31e-04 | 963 | 69 | 8 | 28671696 | ||
| Pubmed | Adaptor proteins NUMB and NUMBL promote cell cycle withdrawal by targeting ERBB2 for degradation. | 6.49e-04 | 19 | 69 | 2 | 28067668 | |
| Pubmed | LIM-homeodomain gene Lhx2 regulates the formation of the cortical hem. | 6.49e-04 | 19 | 69 | 2 | 11165475 | |
| Pubmed | 7.20e-04 | 20 | 69 | 2 | 33888907 | ||
| Pubmed | 7.78e-04 | 549 | 69 | 6 | 38280479 | ||
| Pubmed | 7.95e-04 | 21 | 69 | 2 | 18353970 | ||
| Pubmed | 8.73e-04 | 22 | 69 | 2 | 12871600 | ||
| Pubmed | The imprinted Phlda2 gene regulates extraembryonic energy stores. | 8.73e-04 | 22 | 69 | 2 | 19884348 | |
| Pubmed | Lack of Flvcr2 impairs brain angiogenesis without affecting the blood-brain barrier. | 8.73e-04 | 22 | 69 | 2 | 32369453 | |
| Pubmed | 9.55e-04 | 23 | 69 | 2 | 28811219 | ||
| Pubmed | 9.55e-04 | 23 | 69 | 2 | 33830085 | ||
| Interaction | LMO2 interactions | 6.00e-06 | 310 | 64 | 8 | int:LMO2 | |
| Interaction | ISL2 interactions | 8.57e-06 | 41 | 64 | 4 | int:ISL2 | |
| Interaction | DSCAM interactions | 1.71e-05 | 171 | 64 | 6 | int:DSCAM | |
| Interaction | ACSM5 interactions | 2.79e-05 | 55 | 64 | 4 | int:ACSM5 | |
| Interaction | NIPSNAP3B interactions | 3.90e-05 | 21 | 64 | 3 | int:NIPSNAP3B | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q12 | 6.20e-05 | 8 | 69 | 2 | chr9q12 | |
| Cytoband | 9p13.1 | 6.01e-04 | 24 | 69 | 2 | 9p13.1 | |
| Cytoband | Xq21.1 | 1.14e-03 | 33 | 69 | 2 | Xq21.1 | |
| Cytoband | 11q12.2 | 1.59e-03 | 39 | 69 | 2 | 11q12.2 | |
| Cytoband | 16q24.3 | 2.81e-03 | 52 | 69 | 2 | 16q24.3 | |
| GeneFamily | Fibronectin type III domain containing | 5.09e-04 | 160 | 42 | 4 | 555 | |
| GeneFamily | Immunoglobulin like domain containing | 1.03e-03 | 193 | 42 | 4 | 594 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 2.10e-03 | 394 | 42 | 5 | 471 | |
| GeneFamily | Ankyrin repeat domain containing | 2.35e-03 | 242 | 42 | 4 | 403 | |
| GeneFamily | PDZ domain containing | 5.26e-03 | 152 | 42 | 3 | 1220 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 6.17e-03 | 161 | 42 | 3 | 593 | |
| Coexpression | LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP | 3.57e-07 | 183 | 65 | 7 | M12621 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.38e-08 | 200 | 68 | 7 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.38e-08 | 200 | 68 | 7 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.36e-07 | 180 | 68 | 6 | 544fb373a3346186ec60afe2cfcf141bb04a1eed | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.76e-07 | 191 | 68 | 6 | 3307dbccadb09c62b0e1c0235ec89bb294d748c3 | |
| ToppCell | facs-BAT-Fat-3m-Endothelial-nan|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.06e-07 | 193 | 68 | 6 | e340064cd146deac03f2d0fd43e2e218bb6057c9 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.06e-07 | 193 | 68 | 6 | a3636c35ed25aabe2f1aba016c9fe125327bbfaf | |
| ToppCell | facs-BAT-Fat-3m-Endothelial-endothelial_cell|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.06e-07 | 193 | 68 | 6 | a211b386fd0fb9da9937361d29d90925a72c9715 | |
| ToppCell | facs-BAT-Fat-3m-Endothelial|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.06e-07 | 193 | 68 | 6 | 3086c33f4d6fab66966818737f95ae4d6b2615b0 | |
| ToppCell | LPS-IL1RA-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.21e-07 | 194 | 68 | 6 | 43f92b0533e26633dc94cce554045d641ef8fd76 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.21e-07 | 194 | 68 | 6 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.21e-07 | 194 | 68 | 6 | 1d39d968730a7e85b6161c1c8a6bd38afe9bcad7 | |
| ToppCell | wk_08-11-Endothelial-Blood_vessel_endothelial-Early_cap|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 5.54e-07 | 196 | 68 | 6 | 0f00aac6dac699507ce336020b2e96fd192de0be | |
| ToppCell | Control_saline|World / Treatment groups by lineage, cell group, cell type | 6.05e-07 | 199 | 68 | 6 | 11c9c1779caceb725ecccf3f23b7d4e6dbd1af64 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.23e-07 | 200 | 68 | 6 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | LPS_only-Endothelial|LPS_only / Treatment groups by lineage, cell group, cell type | 6.23e-07 | 200 | 68 | 6 | 81e76508c9050d533853d5fd2f3097b27613d836 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 6.23e-07 | 200 | 68 | 6 | 3b97920e1e6e2f09ddba2a861baa9c00c2970f4c | |
| ToppCell | Control_saline-Endothelial-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type | 6.23e-07 | 200 | 68 | 6 | e77eba6172cabf85b8028638ed35299f2f079cd8 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.23e-07 | 200 | 68 | 6 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.23e-07 | 200 | 68 | 6 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.23e-07 | 200 | 68 | 6 | b70b7adb7c187e6253c7f0bb4c1f09c85ef7142c | |
| ToppCell | LPS_anti-TNF-Endothelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.23e-07 | 200 | 68 | 6 | 1d105eeda5a2c51f9a4654ffc79b7e2348ad593b | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.23e-07 | 200 | 68 | 6 | b2d4e6f3e8e4da62e6b02758ab2ed8f505269f9a | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.23e-07 | 200 | 68 | 6 | 60d2cbf41f37f1b11eddb4c9d9246c9c1fc5a5af | |
| ToppCell | Control_saline-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type | 6.23e-07 | 200 | 68 | 6 | 3372c488a39fe812fa94e4f0564594186fea3db5 | |
| ToppCell | LPS_only-Endothelial-Endothelial|LPS_only / Treatment groups by lineage, cell group, cell type | 6.23e-07 | 200 | 68 | 6 | 4bb609a284d4e6066f17470a1736076aa4a1f84c | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.40e-06 | 165 | 68 | 5 | 62457b7b74c6eae42d91d65e7dc6df6bf8e061f7 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.56e-06 | 166 | 68 | 5 | 7a45785a40b7425f97be67bab1c5ceb69b2bd85a | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.56e-06 | 166 | 68 | 5 | bbd382812f8a84a5d99888de2d7cca3a8b5e4695 | |
| ToppCell | Control-Endothelial_cells-Systemic_venous_endothelial_cells|Control / group, cell type (main and fine annotations) | 6.61e-06 | 172 | 68 | 5 | c55dce1ed3ed7312394b4e050e1de852a994e130 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC-cycling_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.99e-06 | 174 | 68 | 5 | 42735f6a8e5ec36dd3d35aceea6d37cf3eaa1871 | |
| ToppCell | Control|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.59e-06 | 177 | 68 | 5 | b8ff6940e31b749776e81ae4f5bbd577dba9749c | |
| ToppCell | E17.5-Endothelial-capillary_endothelial_cell-capillary_endothelial_cell_of_alveolus|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.81e-06 | 178 | 68 | 5 | 982205ba117a4c7b7e9b713689a5b69190f0bca9 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.24e-06 | 180 | 68 | 5 | af2bafcd1b2082629de3ea336711add01565c4c4 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Alv_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.24e-06 | 180 | 68 | 5 | 30cf3c7ee29694eaccb89bf8053a82037d5c9f1d | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.24e-06 | 180 | 68 | 5 | f29a995cf6e1a1836ed68b73258d9370bf3d4434 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.46e-06 | 181 | 68 | 5 | 4d7793026373cbcf04b15c77f95f1025d07d4c00 | |
| ToppCell | COVID-19-Endothelial_cells-Capillary_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 8.46e-06 | 181 | 68 | 5 | c5f9c92af1384d9089c65afdf41c6feb8345a3ae | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.93e-06 | 183 | 68 | 5 | 3427f3cbe6ea81709750e7dd3ff378f03ae65eab | |
| ToppCell | 3'-Child09-12-SmallIntestine-Endothelial-blood_vessel_EC-Mature_arterial_EC|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.17e-06 | 184 | 68 | 5 | 842473fa415575441b595073a994b6d621169776 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.41e-06 | 185 | 68 | 5 | 0ab1be455f2cd883c9d1522ca78112c37833352e | |
| ToppCell | droplet-Heart-nan-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.66e-06 | 186 | 68 | 5 | 0ae5fbe9f210cb25092394267e1d3d6ed05627b8 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Endothelial-endothelial_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.91e-06 | 187 | 68 | 5 | 3548a9914c2b2f5d805798ce22ab26eab6d03897 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Endothelial-endothelial_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.91e-06 | 187 | 68 | 5 | f4de4b7af1fdfbd628b1f509c060c1079d2e5437 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.91e-06 | 187 | 68 | 5 | d6765854154557794815514c0aa355bc74b8523e | |
| ToppCell | P03-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_artery|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 9.91e-06 | 187 | 68 | 5 | 66ebe1788d51b3e17bec6cdb219f709756b4e530 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Endothelial|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.91e-06 | 187 | 68 | 5 | 81754e965848b718be20ee97ce072ce426938a69 | |
| ToppCell | facs-Heart-RA-18m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-05 | 189 | 68 | 5 | 1be5067c1e45af7d09c1fd6955952cb9e031a3a0 | |
| ToppCell | facs-Heart-RA-18m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-05 | 189 | 68 | 5 | 30dc1725d43a60017fb12d706f1f85a33de4947e | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like|lymph-node_spleen / Manually curated celltypes from each tissue | 1.07e-05 | 190 | 68 | 5 | 0c7eb8f4f2926af01bf44d5c9f239be7b81c67fe | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.07e-05 | 190 | 68 | 5 | 06bfb62b94b0faf467ef93d5bc5d08924c770098 | |
| ToppCell | PND01-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.07e-05 | 190 | 68 | 5 | eae5bcdb8a35f3fba4d25854c1a43f83f80832a2 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.07e-05 | 190 | 68 | 5 | 474cbbab8f3b0a6881fa6c92edb78e43999f9ab0 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.07e-05 | 190 | 68 | 5 | d87b9e9ca863270a9c7f61674271a6440c97d1f4 | |
| ToppCell | PND01-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.07e-05 | 190 | 68 | 5 | 3346bfd0474828b3729cffa9f4cc57b04dd30443 | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_D3|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.10e-05 | 191 | 68 | 5 | d7920f4a602b50d0ef064eb47001e71939695ed2 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.10e-05 | 191 | 68 | 5 | a7b18bcf27c38ad2353c239ecb309c80f3ef3359 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.13e-05 | 192 | 68 | 5 | 285a9d332a1e07b94f222d4b518dd56928b9e075 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.13e-05 | 192 | 68 | 5 | c618ede75dce3988c87a5b8f98d8e94e1dd66efd | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.13e-05 | 192 | 68 | 5 | 04f5a2e3dd6beff027b89d66eefdd92036e041af | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.13e-05 | 192 | 68 | 5 | c07d7b40b2aa4eb27ac85801c014a656e2fd01dc | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.13e-05 | 192 | 68 | 5 | 1f35efb0765e05f7f9c881849953bef3965be25a | |
| ToppCell | droplet-Bladder-BLADDER-1m-Endothelial|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-05 | 193 | 68 | 5 | 3a5090f81f35026f435f4a250d1e77601a53af15 | |
| ToppCell | droplet-Fat-Mat-18m-Endothelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-05 | 193 | 68 | 5 | 54024a373e42e1c0bcc327dc084564b83b63a9d4 | |
| ToppCell | droplet-Fat-Mat-18m-Endothelial-endothelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-05 | 193 | 68 | 5 | 81d908594d2983ba7e7c1ec25afdde4315d9690e | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.15e-05 | 193 | 68 | 5 | 02f633b016ab19bfa65bfd0cf32f000549a62148 | |
| ToppCell | Control-Endothelial-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.15e-05 | 193 | 68 | 5 | aff0649c73c634bc6ff0dc7759b4693a9236bf05 | |
| ToppCell | Control-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.15e-05 | 193 | 68 | 5 | c5f9fe03e64c211d4bcd4959e5b32f14841e336a | |
| ToppCell | droplet-Bladder-nan-3m-Endothelial-endothelial_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-05 | 193 | 68 | 5 | 8be24713f8ba2545b7647d1994e9e993623ddaa3 | |
| ToppCell | Control-Endothelial-Endothelial-Gen_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.15e-05 | 193 | 68 | 5 | e1d546165dcc2392f540162206852c4717d7306f | |
| ToppCell | droplet-Bladder-nan-3m-Endothelial-endothelial_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-05 | 193 | 68 | 5 | 19dfc4a2c91fcea4f5991e7c44df46faeecb06b8 | |
| ToppCell | droplet-Bladder-BLADDER-1m-Endothelial-endothelial_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-05 | 193 | 68 | 5 | 13731b7fc1e3bec0cebc44bad7e2ecea358bb76a | |
| ToppCell | LPS-antiTNF-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.15e-05 | 193 | 68 | 5 | 5122b1ffba42de190061be34ecdc6176f84e56a3 | |
| ToppCell | droplet-Bladder-nan-3m-Endothelial|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-05 | 193 | 68 | 5 | 351e0acd411a9eb0dbc0e358d0d1e3759753fa40 | |
| ToppCell | droplet-Bladder-BLADDER-1m-Endothelial-endothelial_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-05 | 193 | 68 | 5 | 88cd7d0d0da5c776b49fc131f746fe5ad9676fb7 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.15e-05 | 193 | 68 | 5 | 1d8acf81dcbfe81c7a73ce50c9f38fe0cbc74486 | |
| ToppCell | T_cells-CD56_bright_CD16-_NK_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 1.15e-05 | 193 | 68 | 5 | 826457e2aafdb61ead8a0a44d8cf9088d310684b | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.15e-05 | 193 | 68 | 5 | 0f2967afbbf4e538b63f985c0acc2e5d9aab7589 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.15e-05 | 193 | 68 | 5 | 097a244cf37ce6c1ace9bae56beb7de59442cd6b | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.15e-05 | 193 | 68 | 5 | 58c590dd6f21bc7ae58ae1729dd574c0f1069592 | |
| ToppCell | PND10-Endothelial|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.15e-05 | 193 | 68 | 5 | f3c743b340fc588bc8effd375b12e2c7cbfa49d2 | |
| ToppCell | LPS_only-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.18e-05 | 194 | 68 | 5 | 58f069efdefa0366033764446b9d6ffd4a17807e | |
| ToppCell | LPS_only-Endothelial-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.18e-05 | 194 | 68 | 5 | bfd92ec75facb0ba55c31e5f2e089d983b3d0169 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.18e-05 | 194 | 68 | 5 | f93f5148b136819d87faef89707dbaba07d6c2b5 | |
| ToppCell | droplet-Fat-Mat-18m-Endothelial-Cd36+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-05 | 194 | 68 | 5 | 74d0eaa76f6d9af14110dfe5b4bf9751b99ff6e3 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.21e-05 | 195 | 68 | 5 | d700e959e060932e3854a9cf294799465efbe18b | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-innate_lymphocytic|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.21e-05 | 195 | 68 | 5 | 63e132fd6e4318299dd47bbe8ed3bf120efe46dd | |
| ToppCell | wk_20-22-Endothelial-Blood_vessel_endothelial-GRIA2+_arterial_endo|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.21e-05 | 195 | 68 | 5 | a432d69b0172211ee4d53675936a1dc9ce1ae1f0 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.24e-05 | 196 | 68 | 5 | cf7f384c1771274e766bab03ecc3dfbd13f2df60 | |
| ToppCell | PND03-Endothelial|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.24e-05 | 196 | 68 | 5 | a529681d822a95dd1980b7b1c71dc61aaf0baecd | |
| ToppCell | cellseq-Epithelial-Epithelial_Alveolar-AT1-AT1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.24e-05 | 196 | 68 | 5 | 6731fef8c148b6681d6ed38afdf23c8213e0bbbe | |
| ToppCell | cellseq-Epithelial-Epithelial_Alveolar-AT1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.24e-05 | 196 | 68 | 5 | 6856317cd0cdcb88fe54b4ae905d91e13495b1c4 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.27e-05 | 197 | 68 | 5 | 98e34e8612f111bb667a574de1faaa785d318ca4 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_immature|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.27e-05 | 197 | 68 | 5 | 62c0a90869431e582bb7bb329e0b0cc59123d3d1 | |
| ToppCell | Parenchyma_Control_(B.)-Endothelial-TX-Endothelial-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.27e-05 | 197 | 68 | 5 | f969685dee212f33a6f09e54c0cd1fd24ffef546 | |
| ToppCell | (4)_Blood_vessel|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 1.27e-05 | 197 | 68 | 5 | 1b82979a41ef46c814c82527a585900586d71260 | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial-Endothelial-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.27e-05 | 197 | 68 | 5 | 1a137af40697137bb9d2b5caf2b1ffda55f04461 | |
| ToppCell | (4)_Endothelial_cells|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 1.27e-05 | 197 | 68 | 5 | dd9abb43c23e7698433e455eacbf5b23b0a756c2 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.27e-05 | 197 | 68 | 5 | 16f0eb047df9d702518f82ee99c6e7dc1350b2fb | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial-Endothelial-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.27e-05 | 197 | 68 | 5 | 96d63a8d00583e2aa0a38412e2ae27e23f399493 | |
| ToppCell | tumor_Lung-Endothelial_cells-Tumor_ECs|tumor_Lung / Location, Cell class and cell subclass | 1.31e-05 | 198 | 68 | 5 | 5228c4bf2513186140c2c4eaa67a268c732bdc84 | |
| Disease | systemic scleroderma (is_marker_for) | 1.83e-04 | 53 | 61 | 3 | DOID:418 (is_marker_for) | |
| Disease | creatine kinase measurement | 2.52e-04 | 59 | 61 | 3 | EFO_0004534 | |
| Disease | retinopathy of prematurity (biomarker_via_orthology) | 2.74e-04 | 12 | 61 | 2 | DOID:13025 (biomarker_via_orthology) | |
| Disease | uveitis (is_marker_for) | 3.23e-04 | 13 | 61 | 2 | DOID:13141 (is_marker_for) | |
| Disease | intercellular adhesion molecule 5 measurement | 3.23e-04 | 13 | 61 | 2 | EFO_0008164 | |
| Disease | pre-eclampsia (implicated_via_orthology) | 3.23e-04 | 13 | 61 | 2 | DOID:10591 (implicated_via_orthology) | |
| Disease | third ventricle volume measurement | 4.34e-04 | 15 | 61 | 2 | EFO_0010335 | |
| Disease | lung cancer (is_implicated_in) | 4.91e-04 | 74 | 61 | 3 | DOID:1324 (is_implicated_in) | |
| Disease | Uremia | 5.60e-04 | 17 | 61 | 2 | C0041948 | |
| Disease | liver cirrhosis (is_marker_for) | 6.63e-04 | 82 | 61 | 3 | DOID:5082 (is_marker_for) | |
| Disease | ICAM-1 measurement | 1.13e-03 | 24 | 61 | 2 | EFO_0004520 | |
| Disease | mean reticulocyte volume | 1.27e-03 | 799 | 61 | 7 | EFO_0010701 | |
| Disease | Cerebral Hemorrhage | 1.53e-03 | 28 | 61 | 2 | C2937358 | |
| Disease | pneumonia (is_marker_for) | 1.53e-03 | 28 | 61 | 2 | DOID:552 (is_marker_for) | |
| Disease | Epileptic encephalopathy | 1.76e-03 | 30 | 61 | 2 | C0543888 | |
| Disease | Carcinoma, Granular Cell | 1.80e-03 | 116 | 61 | 3 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 1.80e-03 | 116 | 61 | 3 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 1.80e-03 | 116 | 61 | 3 | C0205642 | |
| Disease | Carcinoma, Cribriform | 1.80e-03 | 116 | 61 | 3 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 1.80e-03 | 116 | 61 | 3 | C0205641 | |
| Disease | Adenocarcinoma | 1.80e-03 | 116 | 61 | 3 | C0001418 | |
| Disease | serum alanine aminotransferase measurement | 2.05e-03 | 869 | 61 | 7 | EFO_0004735 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SKSQDRMAPPQNQWP | 1236 | P55196 | |
| RMAPPQNQWPNYEEK | 1241 | P55196 | |
| SRPWPEAMQLITGQP | 1176 | P12821 | |
| KMSPRVPQQDWLSQP | 46 | P11308 | |
| PDVNVQGPDWHLKMP | 2881 | Q09666 | |
| PVPEQGWRNKGAMII | 186 | Q4G176 | |
| PQGQWASKPRMNEGT | 191 | Q8N1I8 | |
| NLQMKEQPGSPEWIQ | 211 | O00170 | |
| GDMQGWEAPAPQRPL | 541 | Q8IY67 | |
| VNPFPKDRWNNTPMD | 611 | O94925 | |
| KRPTMWNVSNNPARP | 381 | Q8N9V6 | |
| IKTEPDAPQPMGPNW | 491 | Q9NPA2 | |
| PKPIMDRWENQGSPQ | 691 | Q86UL8 | |
| QKWQRMVAPPAEPTR | 276 | Q86U70 | |
| MSKPNVDPQPWFQDG | 326 | Q9UGP4 | |
| AKEEWNMDPLPPNQG | 311 | P0C025 | |
| ERTPQGPLAVPMWNK | 1336 | Q9P2D0 | |
| NPDTPEAPRWKQMLT | 4586 | Q03001 | |
| NFEGPPRLKEDQPWM | 206 | Q9BTV5 | |
| FQKWQRMVAPPAEPT | 236 | O43679 | |
| PQDRPRSQGMDSKPW | 6 | Q8NA70 | |
| MNPSEMQRKGPPQRW | 1 | P61583 | |
| TGQGDPPDNMKNFWR | 61 | Q9UHB4 | |
| RLQNLLSGPWPKQPM | 26 | Q8TDS5 | |
| ANVNAMPRQPNPDWR | 806 | Q9H158 | |
| NQGWKKAPLPGPMQQ | 341 | Q14686 | |
| PQGLLMPAPAWDQGN | 111 | Q3B8N5 | |
| GMQRFNPNISWQPIP | 126 | P11117 | |
| QGRRWPLMIDPQDQA | 3071 | Q9C0G6 | |
| QQDMPLRGPGRLQWT | 66 | P49918 | |
| QSDTKMQWPEVPALP | 6 | Q9NZ38 | |
| INSSQEPAPGMKPNW | 861 | Q5U5Z8 | |
| KWPNSVMAPGRGPER | 96 | Q6PJG2 | |
| AWEAKGPNMPGSQPQ | 2441 | Q8IWT3 | |
| TPMCQAWGNPLPELK | 416 | P05362 | |
| LGQSEPEKWMLPPQG | 66 | Q7Z3D6 | |
| IPMWVDNVQCPKGPD | 886 | Q86VB7 | |
| QTQPPKGWLEAMEEP | 406 | O75155 | |
| GRTNQSIMIQWQPPP | 701 | Q58EX2 | |
| NMGPGKVQIWRSQPV | 681 | Q8TDX9 | |
| MIPIWKQQARPGDGP | 61 | Q96HA8 | |
| EGNPNWLQGEPPRMQ | 126 | Q9BQI9 | |
| PQKLPEHMNPPAAWE | 61 | Q8N8U3 | |
| AKPHQMPWQLPLEQR | 456 | O15034 | |
| QWSSMRTEPVKPVPQ | 346 | Q8IYX7 | |
| PFWNMGENSKQLPGP | 381 | Q5VVP1 | |
| PFWNMGENSKQLPGP | 381 | Q8IWB4 | |
| TPRQQVKPPWMAFRG | 96 | Q9NQW5 | |
| LPDINQPDMKQPDTW | 66 | Q86VE3 | |
| QPDMKQPDTWQLGRS | 71 | Q86VE3 | |
| PRQPNKSPPGMWQRG | 426 | Q86VE3 | |
| PCMPQKAPRQDVWER | 211 | Q9H3Y6 | |
| PRLWDIKVQGPPMFQ | 146 | Q9Y2M2 | |
| EMNPPSPSNPRDWLN | 611 | Q6ZVT6 | |
| KVLTMSGWNPPPGNR | 216 | O75153 | |
| PFWNMGENSKQLPGP | 381 | Q5VYP0 | |
| WMRENVPGEKKPQNG | 111 | P55822 | |
| PFWNMGENSKQLPGP | 381 | Q5TZJ5 | |
| PFWNMGENSKQLPGP | 381 | Q5VU36 | |
| QDWAMQSPGQPGDLP | 701 | Q9H6E5 | |
| GKPVQMPSLNWPEAL | 1071 | Q96MS0 | |
| RNWYRGDNPNKPMNP | 206 | P53007 | |
| CAQPTMPWQDGPKQT | 211 | P40238 | |
| PWGLNMQAAQPKGNP | 291 | P59923 | |
| SGNPPPQIMWFKDNE | 691 | P35968 | |
| DLNRQGPPPTIVEWM | 391 | Q9UBN4 | |
| QPDWRQNMGPPTFLA | 31 | A6NP61 | |
| CNPRQSPMNPWLKDT | 151 | A8K8V0 | |
| TMGLQWQPQSPRPGA | 81 | Q6NSI3 | |
| PWESPQVPPDRQKGM | 666 | Q8NFW9 | |
| GWMPQGSPEVLRVKN | 3881 | P20929 | |
| QSFLPPGWEMRIAPN | 496 | Q96PU5 |